RESULTS
CEA with the Decision Tree: The antimicrobial dressing strategy is dominant compared to standard transparent dressings. The intervention prevents 0.0135 CRBSI (13.5 / 1,000) and saves €157 per patient (Fig. 3A) . These results are robust across a range of values for several parameters in DSA (Fig. 3B) OBJECTIVE To compare the results of cost-effectiveness analysis (CEA) for the transparent CHG dressing versus standard transparent dressings, obtained with a classical decision tree model and with a Non-Homogeneous Markov Model (NHMM) previously developed 2 .
A B dermatitis and two absorbing states (death and discharge of the ICU) (Fig. 1 ).
The decision tree was built with the TreeAge Pro® software 2013 (Fig. 2) .
CEA with the NHMM: The simulation of 1,000 patients per group shows 12 infections avoided with the use of the antimicrobial dressing. The mean cost difference of +€141 for the CHG-dressing group is not statically significant. DSA shows that this difference is more sensitive to the additional ICU LOS due to CRBSI (Fig. 3C ). One-way deterministic (DSA) and probabilistic cost-effectiveness sensitivity (PSA) analyses were conducted on key clinical and economic parameters.
DISCUSSION and CONCLUSIONS
Although the Decision-tree and the NHMM are structurally different their outcomes are coherent (Table 2) . However, the antimicrobial dressing strategy appears DOMINANT with the Decision tree and COST-EFFECTIVE with the NHMM Model. The mean difference in cost per patient with CHG-dressings is negative with the decision-tree, indicating savings, and positive with the NHMM, indicating extra cost even not statistically significant. Possible interpretations for the differences between the two modelling approaches are:
1) The decision-tree as a linear simplification, with less health states and disregarding possible state's change or recurrence, can overestimates the real savings.
2) NHMM is prone to overestimate the real costs in the CHG-dressing group by integrating the cost impact of a substantial number of patients being discharged or dying sooner than assumed in the time horizon chosen (because of competing risks). 
